1999
DOI: 10.1007/s004310051009
|View full text |Cite
|
Sign up to set email alerts
|

The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia

Abstract: We suggest giving consideration to hypocitrullinaemia as a hallmark of the neurogenic weakness, ataxia and retinitis pigmentosa syndrome mutation and more generally of impaired oxidative phosphorylation in the small intestine in vivo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
36
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 10 publications
3
36
0
Order By: Relevance
“…The blot was probed with anti-SMVT antibody and expression was normalized relative to b-actin istic unique to patients with the m.8993T>G mutation, seen in 90% of patients, as opposed to less than 20% for other respiratory chain deficiencies (Rabier et al 1998). These findings are sufficiently convincing to consider hypocitrullinemia as a useful biochemical marker for the m.8993T>G mutation and, more generally, as a marker of impaired oxidative phosphorylation in the enterocyte (Rabier et al 1998;Parfait et al 1999;Debray et al 2010;Henriques et al 2012;Mori et al 2014).…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…The blot was probed with anti-SMVT antibody and expression was normalized relative to b-actin istic unique to patients with the m.8993T>G mutation, seen in 90% of patients, as opposed to less than 20% for other respiratory chain deficiencies (Rabier et al 1998). These findings are sufficiently convincing to consider hypocitrullinemia as a useful biochemical marker for the m.8993T>G mutation and, more generally, as a marker of impaired oxidative phosphorylation in the enterocyte (Rabier et al 1998;Parfait et al 1999;Debray et al 2010;Henriques et al 2012;Mori et al 2014).…”
Section: Discussionmentioning
confidence: 93%
“…Persistent hypocitrullinemia has previously been reported in 13 patients with the m.8993T>G variant (Rabier et al 1998;Parfait et al 1999;Enns et al 2006;Debray et al 2010;Henriques et al 2012;Mori et al 2014). In an additional report, a female patient who was prenatally diagnosed with apparently mild ornithine transcarbamylase (OTC) deficiency succumbed during an acute febrile encephalopathic illness at 6 months of age, with neuroimaging suggestive of Leigh syndrome.…”
Section: Discussionmentioning
confidence: 96%
“…Persistent hypocitrullinemia has been seen in patients with mitochondrial disorders (Atkuri et al 2009) including patients with Pearson syndrome (OMIM 557000) (Ribes et al 1993), m.8993T>G-associated Leigh syndrome/ NARP (OMIM 516060) (Rabier et al 1998;Parfait et al 1999;Enns et al 2006;Debray et al 2010;Henriques et al 2012), and mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes syndrome (MELAS, OMIM 540000) (Perry et al 1989;Koga et al 2005;Naini et al 2005). Hypocitrullinemia is also associated with secondary mitochondrial respiratory chain dysfunction caused by organic acidemias (Atkuri et al 2009), deficiency of mitochondrial pyrroline-5-carboxylate synthase (P5C) (Rabier and Kamoun 1995;Baumgartner et al 2000), or intestinal malrotation in newborns (Cavicchi et al 2009).…”
Section: Discussionmentioning
confidence: 98%
“…We detected hypocitrullenimia in plasma from mitochondrial and organic acidemia subjects. Hypocitrullinemia has also been reported in some individuals with Reye syndrome, MELAS, and NARP (21)(22)(23). Low levels of plasma citrulline are a classic biochemical hallmark of proximal urea cycle disorders.…”
Section: Discussionmentioning
confidence: 99%
“…Low levels of plasma citrulline are a classic biochemical hallmark of proximal urea cycle disorders. In addressing the relationship between citrulline levels and mitochondrial function, it has been postulated that primary deficiencies in OXPHOS result in decreased citrulline synthesis via secondary impairment of carbamyl phosphate synthetase I, an early urea cycle enzyme that plays a key role in citrulline synthesis (23), or by inhibiting production of the citrulline precursor ⌬-1-pyrroline carboxylate through inhibition of proline oxidase (22).…”
Section: Discussionmentioning
confidence: 99%